• Nanotechnology presents unprecedented benefits to the cannabis industry​

• Geyser Brands plans to pair nanotech formula with newly acquired consumer brand​

• Geyser is focused on allocating more resources to serve underserved countries

It's no secret that the last five years have been good to the cannabis industry. Though legalization has yet to roll out worldwide, the stigma surrounding cannabis usage has begun shifting to a more widespread acceptance of the plant’s benefits. In Canada alone, the legal market is tracking to be worth $5 billion by 2021, which is a conservative estimate as Canada has one of the highest numbers of cannabis users.

Along with the countless businesses riding this wave, so too are scientists. An arms race of innovation has begun to explore the varied health and wellness applications of cannabis.

At the bleeding edge of this research and development is nanotechnology — the study and application of extremely small things. While nanotechnology has been used in the food and medicine industries for some time, its potential with cannabis is only starting to be explored.

Molecule illustration of nanoparticles.

Nanotechnology is an integral way for human to absorb non-water-soluble ingredients in medication. Because nanoparticles are directly absorbed into the bloodstream, they can deliver quicker and more effective uptake of medications.

Nanotech should continue to gain momentum in North America, which has an aging population of now more than 70 million baby boomers. From cancer treatment to time-released sleeping aids, scientists are only scratching the surface of its potential.

Cannabis company advancing nanotechnology with health and wellness brand acquisition

Geyser Brands Inc (TSXV: GYSR) is one such company that is pushing the cannabis market further through the use of nanotechnology. Headquartered in British Columbia, Geyser is ready to take full advantage of Canada’s cannabis laws.

The company builds health-based hemp CBD consumer products in the nutraceutical, cosmetics, food & beverage, as well as pet sectors worldwide. With their recent acquisition of Solace Management Group Inc, a consumer wellness company with a diverse set of brands, Geyser Brands, CEO and Co-Founder, Andreas Thatcher says that Geyser is working hard to become a well-known and trust brand all over the world.

The company is leveraging its assets to provide the regulatory infrastructure for a global brands and distribution strategy, acquiring hemp and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. Additionally, Geyser is building an integrated production chain and formulation lab that will develop these innovative, consistent, and trustworthy products.



“Our goal is to create products that will fit into peoples’ lives."

— Andreas Thatcher, CEO & Co-Founder, Geyser Brands Inc.

Technological innovations make for a better product

When it comes to using nanotech for cannabis consumer products, the company’s advantages are innumerable. Geyser is slowly bringing the technology into all of its products — from a business standpoint, it oﬀers shelf stability, dosage control, and a much safer product devoid of solvents, toxic fillers or inflammatory ingredients.

In this regard, the high standards of product quality that Solace has become known for can be met consistently. With its anticipated R&D licence, it will invest in product development and clinical trials to promote the acceptance of products and brands in all markets.

A major benefit that Geyser has discovered with their nanotech formula is that it gives a much milder taste profile than other edible products. "Our products don't have that bitterness commonly associated with cannabis edibles," explains Thatcher. This is also a critical point that will give them an edge when legislation regarding edibles in Canada is passed later this year.





An experienced team paving the path to success

While Geyser is expecting to receive its R&D and sales license in the next few months, the company already has its cultivation license coupled with Solace’s branding infrastructure.

The pedigree of the people involved is proof that Geyser is poised to meet and exceed the inevitable challenges ahead. With Thatcher at the helm, the team already has a wealth of experience in finance and product launches. He notes, "In the entertainment business, I was launching up to 15 film and TV projects every year.” This is expertise that will no doubt come in handy in relation to Solace's product development and branding.

In the R&D department, Geyser has a critical player in Kuldip Gill. "Probably the top formulator in Canada. He's got an amazing track record," Andreas says proudly. "He's the guy who introduced cayenne pepper as the basis for a pain cream in the west. If you go into Costco and see Lakota products, that's his original formula." Gill is now applying his impressive knowledge base and experience to all of Geyser's Cannabis products.

From the vast experience of their collective, Geyser has a lot of ground covered already, not to mention the former CEO of Emerald Health acting as an advisor. "Bin Hua is on our Board of Directors and is pivotal on the R&D side of things. With the combination of a Ph.D. and an MBA in plant biology, she's instrumental in our relationship with Health Canada as she's gone through these processes before.”

Worldwide expansion plans

With everything in place to start building the new name in trusted consumer cannabis, Geyser is also prepping to scale up internationally.

Because of the uncertainty of full U.S. legalization, the company has chosen to allocate its resources to countries it feels are underserviced.

“China is a big market for us because we're looking to develop some joint ventures there for a CBD oil supply chain." This is a market problem that Thatcher says is the “consequence of lacking supply consistency.”

Geyser is currently working directly with the Chinese governments, farmers and biotech companies to start building partnerships that will secure a surplus of CBD. They're also building out distribution there as well as across Europe.

As the global cannabis industry could be worth as much as $130 billion in a decade, Geyser is poised to start serving the bulk of that market and be a leader within its industry.

To learn more about Geyser Brands, see their website here.